Literature DB >> 9494613

Microsatellite instability is uncommon in young patients with renal cell carcinoma.

N Kanomata1, J N Eble, K C Halling.   

Abstract

Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal, dominantly inherited syndrome which predisposes to the development of colorectal cancer and, to a lesser extent, other extracolonic neoplasms. Widespread microsatellite instability is a feature of nearly all tumors from patients with hereditary non-polyposis colorectal cancer. It was recently found that most patients under age 35 with colorectal cancer also have widespread microsatellite instability in their tumors and that many of these patients have the germline mutations of mismatch repair genes that characterize hereditary non-polyposis colorectal cancer. Renal cell carcinoma has occasionally been reported in patients with hereditary non-polyposis colorectal cancer, and some renal cell carcinomas have been shown to have microsatellite instability at multiple loci. For this reason, we sought to address the possibility that some young patients with renal cell carcinoma may have hereditary non-polyposis colorectal cancer by screening their tumors for microsatellite instability. Thirty-two patients under the age of 45 with renal cell carcinoma were examined for the presence of microsatellite instability in their tumor tissue. Microsatellite instability was not observed in any of the tumors. The absence of microsatellite instability in renal cell carcinomas from young patients suggests that these patients are unlikely to have hereditary non-polyposis colorectal cancer and would generally not benefit from genetic screening for this syndrome.

Entities:  

Mesh:

Year:  1998        PMID: 9494613     DOI: 10.1016/s0165-4608(97)00229-x

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  1 in total

1.  The extracolonic cancer spectrum in females with the common 'South African' hMLH1 c.C1528T mutation.

Authors:  Maria M Blokhuis; Paul A Goldberg; G Elize Pietersen; Ursula Algar; A Alvera Vorster; Dhiren Govender; Raj S Ramesar
Journal:  Fam Cancer       Date:  2007-11-30       Impact factor: 2.375

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.